Home Medizin Blutdruckmedikamente könnten bei Kindern und jungen Erwachsenen mit ASD helfen, die Angst zu verringern

Blutdruckmedikamente könnten bei Kindern und jungen Erwachsenen mit ASD helfen, die Angst zu verringern

von NFI Redaktion

According to a recent study at the Thompson Center for Autism and Neurodevelopment at the University of Missouri, it was found that Propranolol, a medication used to treat high blood pressure, can also help reduce anxiety in children and young adults with Autism Spectrum Disorder (ASD).

Given that some people with Autism Spectrum Disorder tend to struggle with anxiety much more than their neurotypical peers, this new finding can greatly benefit those with ASD. David Beversdorf, a clinician at the Thompson Center, led the study with 69 participants over a three-year period. Compared to a placebo group, participants who received Propranolol showed significantly lower levels of anxiety during their 12-week visits while taking the medication. The study also investigated whether there were significant changes in the social communication skills of the individuals, but no significant changes were found.

“The results demonstrate that Propranolol could serve as a helpful intervention in reducing anxiety in people with autism,” said Beversdorf, who also holds appointments at the MU School of Medicine and the MU College of Arts and Science. „This drug has been around since the 1960s and is very affordable. So far, we have not known of any medications specifically targeting psychiatric issues in people with autism, so these results are very promising and can support future research.“

As a practicing physician, Beversdorf has seen firsthand the positive benefits Propranolol can have in improving the overall quality of life for some patients with ASD and their families.

As researchers, we do our best to improve the lives of our patients, and it’s enriching to be part of that. I turned to neurology and knew I wanted to try to find new treatment options and interventions that would benefit people with autism.”

David Beversdorf, Professor of Radiology, Neurology, and Psychology and the William and Nancy Thompson Endowed Chair of Radiology

A recent study, “Randomized Controlled Trial of Propranolol for Social Communication and Anxiety in Children and Young Adults with Autism Spectrum Disorder,“ was published in Psychopharmacology. The research was funded by the US Department of Defense’s Congress-led Medical Research Program.

Source:

University of Missouri-Columbia

Journal reference:

Beversdorf, DQ, et al. (2024) Randomized Controlled Trial of Propranolol for Social Communication and Anxiety in Children and Young Adults with Autism Spectrum Disorder. Psychopharmacology. doi.org/10.1007/s00213-023-06452-1.

Related Posts

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.